DNA Methylation and Schizophrenia: Current Literature and Future Perspective

Area of Science:

• Neuroscience
• Psychiatry
• Genetics

Background:

• Schizophrenia is a complex neuropsychiatric disorder with high heritability and implicated environmental factors.
• Epigenetic factors, such as DNA methylation, are believed to mediate environmental influences in schizophrenia.
• Current diagnostic markers and understanding of schizophrenia's pathophysiology remain limited.

Purpose of the Study:

• To review the role of epigenetic modifications, specifically DNA methylation, in schizophrenia.
• To highlight the limitations of current genome-wide methylation studies and the need for broader population coverage.
• To explore the potential of epigenetic alterations in peripheral tissues as biomarkers for schizophrenia.

Main Methods:

• Literature review of epigenetic studies in schizophrenia.
• Analysis of targeted gene and genome-wide methylation studies.
• Discussion of the integration of DNA methylation and gene expression data.

Main Results:

• Contradictory findings exist in targeted gene methylation studies for schizophrenia.
• Genome-wide methylation studies are limited by sample size, methodology, and population diversity (e.g., African populations).
• Epigenetic markers found in peripheral tissues may reflect changes in functional tissues.

Conclusions:

• Further research is needed to address limitations in current genome-wide methylation studies.
• Integrating DNA methylation and gene expression data is crucial for understanding schizophrenia development.
• Peripheral epigenetic alterations show promise as potential non-invasive biomarkers for schizophrenia.